8-KThe WireRoutine
Shareholder Vote · Company Update
Filed Jan 20, 2021 · 5y ago · Accession 0001193125-21-012440
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- BridgeBio Pharma, Inc.
- Ticker
- BBIO
- CIK
- 1743881
- Form type
- 8-K
- Filing date
- Jan 20, 2021
- Report date
- Jan 19, 2021
- Document
- d113734d8k.htm
- Size
- 55 KB